Responsible for the oversight of technical operations at multiple external partners within the Merck Manufacturing network in support of various commercial products. Interfacing with internal and external stakeholders to ensure effective communication of issues and their timely resolution. Serving as subject matter expert within various product/project teams for the execution of technology transfer and commercial manufacturing of bulk drug substances. Serving as Technical Product Steward for commercial product with end to end (e2e) technical accountability to the value chain management team.

Directed all aspects of drug substance manufacturing including facility design; technology transfer; upstream & downstream operations; procurement & inventory control and equipment validation. Collaborated with senior management and cross functional groups in order to develop manufacturing strategy for biosimilar candidates. Advised on process development activities in an effort to keep cost of goods (COGS) low in order to allow the biosimilar platform to maintain a competitive advantage in the marketplace

Manage the technical services group for the Mid Atlantic Sales Region. Responsible for all aspects of technical support to Pall Life Sciences’ customers, sales specialists, distributors, etc.. General functions included the management of quote preparation; filterability performance; report authorship; filter integrity test performance; and Pall Life Sciences’ fee-based field-services.

Direct the purification, support services and sterile formulation / filling contract manufacturing operations within a three-suite, multi-product facility. Target clients were representative of all phases of drug development (Pre-IND Toxicology, Phases I, II, and III) with therapeutic and diagnostic indications.

Provided first-line product support for the Sales Team, targeting pharmaceutical and biopharmaceutical clients at the manufacturing and process-development levels.

Managed the purification contract manufacturing operations within a newly constructed 75,000 ft2 five-suite, multi-product facility. Target clients were representative of all phases of drug development (Pre-IND Toxicology, Phases I, II, and III) with therapeutic and diagnostic indications.

Initially hired as a Level II Operator to assist with commercial launch facility construction and startup activities for the manufacture of Erbitux®. Promoted to supervising all buffer and component preparation activities associated with Downstream Purification Operation at the completion of construction, technology transfer, initial validation and consistency batches (2002).

Responsible for the purification of cell-culture supernatants and ascites fluids, by utilizing Anion, Cation and Affinity Chromatography Methods, Tangential Flow Filtration, Final Formulation and Filling, resulting in a monoclonal antibody and diagnostic product for clinical and commercial use.